Feedback / Questions
KLTO-202 - Klotho Neurosciences
https://www.prnewswire.com/news-releases/klotho-neurosciences-inc-granted-fda-orphan-drug-designation-for-klto-202-for-treatment-of-amyotrophic-lateral-sclerosis-als-or-lou-gehrigs-disease-302501830.html
Jul 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next